Ora Biomedical

The AI engine Fit Assessment

Beta

Ora Biomedical, Inc. is a pharmaceutical company focused on discovering and developing small molecule therapeutics that target biological aging and age-related diseases. They utilize a high-throughput drug discovery platform, WormBot-AI, to identify interventions that promote healthy aging.

Blurb

Longevity Biotechnology Pharmaceutical Company

HQ Location

Seattle (United States)

Founded

2022

Employees

4

Total funding raised

$965.00K

Last Funding Event

Seed, $720.00K, January 25, 2024

Smart insights

  • 6m headcount growth: 200%
  • 1Y headcount growth: 200%

Developer of digital drug targeting technology designed to target screening with artificial intelligence technology. The company develops small molecule therapeutics that extend lifespan and delay chronic illness by targeting the underlying molecular mechanisms of ageing, enabling researchers for drug discovery, screening, and molecular therapeutics.